EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections

Ryosuke Yamamura, Yu Nagayoshi iD, Kayo Nishiguchi, Hitomi Kaneko, Keiichi Yamamoto, Koki Matsushita, Miho Shimamura, Akihiro Kunisawa, Korin Sakakida, Takeshi Chujo, Masataka Adachi, Yutaka Kakizoe und 4 weitere

mBio · 2025

DOI: 10.1128/mbio.03124-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Ryosuke Yamamura und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Nucleosides, Bacterial Infections, Bacteria. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 170 types of chemical modifications have been identified in cellular RNAs across the three domains of life. Modified RNA is eventually degraded to constituent nucleosides, and in mammals, modified nucleosides are released into the extracellular space. By contrast, the fate of modified nucleosides in bacteria remains unknown. In this study, we performed liquid chromatography-mass spectroscopy (LC-MS) analysis of modified nucleosides from the RNA of 23 pathogenic bacteria, revealing 2-methyladenosine (m 2 A) as a common bacteria-specific modified nucleoside detected in all bacterial RNAs. Under normal culture conditions, bacteria did not actively release most modified nucleoside species, but robustly released nucleosides, including m 2 A, following addition of antibiotics or immune cells. These results indicate that m 2 A is released following bacterial lysis. Intraperitoneal injection of mice with m 2 A increased detectable levels of m 2 A in the urine, indicating that mammals can effectively excrete m 2 A. Additionally, mice infected with wild-type E. coli showed higher levels of m 2 A in their urine than mice infected by m 2 A-deficient rlmN KO E. coli . This suggests that m 2 A from the infected bacteria is excreted in the urine. Lastly, clinical studies using urine samples from febrile patients revealed significantly elevated levels of m 2 A during bacterial infections, and these values did not correlate with inflammation severity markers, such as white blood count (WBC) and C-reactive protein (CRP). This study reports the mammalian metabolism of modified nucleosides derived from bacterial RNA, and the elevation of urinary m 2 A in patients with bacterial infections. IMPORTANCE This study reveals the differences in the fate and release of modified nucleosides in bacteria and mammals. Additionally, our study highlights that external bacteria-damaging factors, such as antibiotics and phagocytosis by host immune cells, promote the release of bacteria-specific modified nucleosides. Furthermore, we found that m 2 A was elevated in the urine from animal models of bacterial infection and the urine of patients with bacterial infections. Collectively, this work spans basic biology and clinical science, offering valuable insights into the fate of modified nucleosides in bacterial systems and their relevance to infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleosidesBacterial InfectionsBacteriaAnimalsMiceHumansRNA, BacterialEscherichia coliChromatography, LiquidMice, Inbred C57BLFemaleAdenosineMale

Stichwörter der Autor:innen

LC-MSRNA modificationbacterial infectionbiomarkermodified nucleoside

Substanzen

NucleosidesRNA, BacterialAdenosine

Autor:innen und Institutionen

  • Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Center for Metabolic Regulation of Healthy Aging, Faculty of Life Science, Kumamoto University, Kumamoto, Japan.
  • Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.

ORCID-Profile: Yu Nagayoshi, Kazuhito Tomizawa

Förderung

  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Yamamura, R., Nagayoshi, Y., Nishiguchi, K., Kaneko, H., Yamamoto, K., Matsushita, K., Shimamura, M., Kunisawa, A., Sakakida, K., Chujo, T., Adachi, M., Kakizoe, Y., Izumi, Y., Kuwabara, T., Mukoyama, M., & Tomizawa, K. (2025). Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections. mBio. https://doi.org/10.1128/mbio.03124-24

Vancouver

Yamamura R, Nagayoshi Y, Nishiguchi K, Kaneko H, Yamamoto K, Matsushita K, et al. Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections. mBio. 2025. doi:10.1128/mbio.03124-24

BibTeX
@article{Yamamura2025,
  author = {Yamamura, Ryosuke and Nagayoshi, Yu and Nishiguchi, Kayo and Kaneko, Hitomi and Yamamoto, Keiichi and Matsushita, Koki and Shimamura, Miho and Kunisawa, Akihiro and Sakakida, Korin and Chujo, Takeshi and Adachi, Masataka and Kakizoe, Yutaka and Izumi, Yuichiro and Kuwabara, Takashige and Mukoyama, Masashi and Tomizawa, Kazuhito},
  title = {Bacteria-specific modified nucleoside is released and elevated in urine of patients with bacterial infections},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.03124-24}
}
Kostenlos starten →